First trimester screening for Down syndrome and assisted reproduction: no basis for concern

Publisher Website
Google Scholar
Abstract
In pregnancies obtained after assisted reproduction the false‐positive rate of second trimester Down syndrome (DS) screening is increased by 1.5–3‐fold. This may cause an increase in the number of amniocenteses and the fetal loss rate. The present study for the first time examined whether assisted reproductive technologies affect the results of first trimester screening. The markers PAPP‐A, free β‐hCG and the nuchal translucency (NT) thickness were examined at 12–14 weeks' gestation. Screening markers in 47 in vitro fertilisation (IVF), 63 ovulation induction (OI) and 3026 spontaneously conceived singleton pregnancies were compared. The MoM (multiples of the median) value in the IVF pregnancies was 1.02 (95% CI: 0.85–1.22) for PAPP‐A, 1.14 (95% CI: 0.95–1.37) for β‐hCG and 0.97 (95% CI: 0.89–1.05) for NT; the MoM value in the OI pregnancies was 0.89 (95% CI: 0.76–1.05) for PAPP‐A, 1.08 (95% CI: 0.93–1.25) for β‐hCG and 1.02 (95% CI: 0.95–1.11) for NT. The first trimester marker values in assisted reproductive pregnancies and spontaneously conceived pregnancies were not significantly different. Estimated false‐positive rates for a risk cut‐off of 1:400 varied from 4.7% in IVF pregnancies to 5.1% in OI pregnancies. Therefore the false‐positive rate in Down syndrome screening should be independent of the method of conception. Copyright © 2001 John Wiley & Sons, Ltd.
Funding Information
  • Danish Medical Research Council
  • The John and Birthe Meyer Foundation
  • The Ivan Nielsen Foundation
  • The Hede Nielsen Foundation
  • The Else and Mogens Wedell-Wedellsborg Foundation
  • The Dagmar Marshall Foundation
  • The Egmont foundation
  • Fetal Medicine Foundation